Rx|X Next Level Community

Your source for all the latest developments in the 340B space

Quick Client Check-In: Exelixis 340B Pricing Access

Help Us Understand Recent Changes in Exelixis 340B Pricing

During a recent call with the American Hospital Association (AHA), Rx|X was made aware that there were new concerns regarding Exelixis potentially limiting 340B pricing access for certain covered entities.

At this time, we are gathering quick feedback from our clients to better understand whether this issue is affecting organizations across our network.

Your responses will help us:

  • Identify whether this issue is widespread

  • Provide summary, anonymized insights back to AHA

  • Determine whether further follow-up or industry guidance may be needed

This short poll should take less than one minute to complete.

Your responses will remain confidential and will only be reported in aggregate form.

We appreciate you taking a moment to share your experience.

Thank you for helping us better understand the current landscape.

Your feedback supports Rx|X in providing informed guidance to our clients and contributing meaningful insight to broader industry discussions.

If we identify trends that may affect our clients, we will provide updates and guidance as appropriate.